/ Sep 30, 2026
/ Sep 30, 2026

Dangote $16bn East Africa refinery breaks ground in Kenya

Published on

By

The groundbreaking ceremony for the $16bn Dangote East Africa Petroleum Refinery and Petrochemicals Special Economic Zone is taking place in Mokowe, Lamu County, Kenya, as the Nigerian industrialist expands his business interests across the continent.

 

According to Channels Television, the proposed refinery is expected to have a processing capacity of 700,000 barrels per day and is targeted for completion by 2030.

The facility is planned to process crude from Kenya’s Turkana oilfields, alongside supplies from other parts of Africa. It is also expected to reduce East Africa’s reliance on imported petroleum products.

Speaking to reporters in Nairobi on Tuesday, Dangote said the project was part of efforts to encourage African countries to process their natural resources locally rather than export raw materials.

He said he expected most African countries to achieve fuel self-sufficiency by 2030, stressing that refining should take place within the continent.

The Lamu project has, however, faced opposition, including a land rights court case and environmental concerns raised by Greenpeace and others.

Dangote said the project would proceed despite the concerns, arguing that large-scale industrial development was necessary for Africa’s economic transformation.

The businessman also disclosed plans to invest an additional $50bn across Africa, after committing more than $25bn to existing businesses.

“We want to create and generate wealth for Africans, to make sure that we defend our markets,” Dangote said during an investor engagement at the Nairobi Securities Exchange.

Africa-focused expansion

Kenya’s President William Ruto’s chief economic adviser, David Ndii, said the Lamu refinery emerged from discussions on how Africa could use its natural resources to drive industrialisation.

He said a meeting in April identified an East African market for finished petroleum products estimated at 20 million metric tonnes annually, with potential to rise to 30 million tonnes.

Ndii said the project was designed to help reverse a pattern in which Africa exports raw materials and imports finished products at higher costs.

Dangote also linked the refinery project to his wider plans to increase African ownership of major businesses operated by his group.

He said the ongoing public offer of Dangote Petroleum Refinery was intended to allow more Africans to participate in the wealth generated by industrial development.

The businessman said the group planned to progressively open more of its businesses to public ownership, including its planned shipping operations and expanding fertiliser business.

He added that if the Lamu refinery eventually becomes publicly listed, he expects it to be listed on the Nairobi Securities Exchange rather than automatically being taken to Nigeria’s capital market.

You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Must Read

Japanese surgeons perform the world’s first heart muscle stem cell surgery using iPS-derived cells

Japan performs world’s first heart muscle stem cell surgery

A hospital in Japan has performed the world’s first surgery using commercially available sheets of heart muscle cells derived from induced pluripotent stem cells, marking a significant step in regenerative heart treatment.   The procedure was carried out on Tuesday at Osaka Keisatsu Hospital on a woman in her 50s. The hour-long operation involved transplanting sheets of heart muscle cells into her heart. The treatment received conditional government approval in Japan in March, allowing its first clinical use. “Our hope is that this will improve the patient’s quality of life,” surgeon Yoshiki Sawa, head of Osaka Keisatsu Hospital, told reporters after the operation. The regenerative therapy was previously tested on eight patients with ischaemic heart disease, a condition in which narrowed heart arteries reduce blood flow to the heart. According to Japanese media reports, all eight patients experienced an easing of symptoms, while four recorded improvements in heart function. Sawa developed the technology in collaboration with Japanese scientist Shinya Yamanaka, who won the 2012 Nobel Prize in Physiology or Medicine for his research into induced pluripotent stem cells, commonly known as iPS cells. iPS cells are created by reprogramming mature specialised cells into a more flexible, juvenile-like state, allowing them to develop into different types of cells. The therapy is primarily intended for heart patients who have exhausted other treatment options. It is expected to help improve heart muscle function, heart failure symptoms, cardiac performance and exercise tolerance. Sawa’s team plans to carry out similar procedures on 75 patients by 2033 as part of efforts to establish the treatment’s effectiveness and safety. The treatment could receive full authorisation if its benefits and safety are demonstrated during the seven-year evaluation period, according to Japanese media reports. Japan also granted conditional approval in March for an iPS cell-based treatment for Parkinson’s disease following a successful clinical trial.
Read more

Editor's Pick

Trending News

Newsletter

Enter your email address and receive notifications of news by email.

You have been successfully Subscribed! Ops! Something went wrong, please try again.

© 2026 GongNews. All Rights Reserved.